Stay updated on Eli Lilly and Company Press Releases
Sign up to get notified when there's something new on the Eli Lilly and Company Press Releases page.

Latest updates to the Eli Lilly and Company Press Releases page
- Check4 days agoChange DetectedNew press releases announce CHMP's positive opinion for Jaypirca in EU CLL and a Europe-wide Memory Radio Station campaign. Older weight-management data involving Foundayo and retatrutide have been removed from the page.SummaryDifference8%

- Check11 days agoChange DetectedNew items were added to the press release list, including Medicare pathway updates for Foundayo and Zepbound, the Centessa acquisition, the Q3 dividend, and the healthcare provider hub. Older press release entries were removed to reflect current archives on the page.SummaryDifference10%

- Check18 days agoChange DetectedAdded new press releases featuring BRUIN CLL-322 data for Jaypirca in CLL/SLL and the first-in-class type II JAK2 inhibitor AJX-101 data with a 2026 EHA presentation (dated 06/13–06/14/2026). Removed older announcements about Foundayo and Zepbound coverage milestones and Lilly's conference participation.SummaryDifference7%

- Check26 days agoChange DetectedNew press releases were added to the page, including a Shaquille O'Neal sleep apnea campaign, EBGLYSS FDA approval, and Foundayo/retatrutide trial results, among others; several older releases about acquisitions and other topics were removed from the listing.SummaryDifference8%

- Check33 days agoChange DetectedThe press releases list has been updated with several new headlines and dates highlighting recent company news and research, while older items such as conference participation and community initiatives have been removed. This update refreshes the page content to reflect current news and priorities.SummaryDifference8%

- Check40 days agoChange DetectedThe press releases page was updated with multiple new entries, including conference participation, three acquisitions in infectious disease, trial updates on VERVE-102 and Foundayo, oncology portfolio showcasing at ASCO, and other corporate news. Older items such as anniversary campaign commitments, dividend declarations, and manufacturing expansion announcements were removed.SummaryDifference9%

Stay in the know with updates to Eli Lilly and Company Press Releases
Enter your email address, and we'll notify you when there's something new on the Eli Lilly and Company Press Releases page.